Download the March 2021 issue of Unquote

Unquote team
02 March 2021

Tweet
Facebook
LinkedIn
Google plus
Send to

This month in Unquote: How the pandemic has created exciting new opportunities in the biotechnology market, attracting investors from new corners of the PE world

Also in this issue:

Nordic players await distressed carve-out uptick
DACH exit rebound expected in H2 2021
Q&A: 17Capital's Thomas Doyle
Our usual in-depth coverage and statistical analysis of activity in each regional market

To download the latest issue of Unquote in PDF format, please click here

Dear subscribers,

We are now nearing a full year of living and working under circumstances none of us could have ever predicted. Like many across the industry, these past few months have led us to move beyond merely adapting to the new normal, and instead rethink the way in which we can best serve the changing needs of our end users.

An early step in this evolution was to pivot our magazine to a PDF format rather than a print product, as most of our subscribers wanted to continue accessing our curated content while away from their offices. This also tied in with long-running feedback from our users, who consistently found more in-depth information, more easily accessible and searchable, on our Unquote.com and Unquote Data platforms.

While a return to normality (and office commutes!) is thankfully now in sight, the move towards a fully digital offering for Unquote is only just beginning. From April onwards, our new monthly Unquote Digest will arrive directly in your e-mail inbox, instead of as a physical copy at your office. Through this new monthly e-newsletter, we will keep bringing you our best scoops, in-depth analysis, exclusive LP/GP interviews and industry news, with added interactive features such as podcasts and videos.

This will expand our reach and your user experience - our most impactful content will be centralised and just a click away for all our subscribers - and reduce Unquote's impact on the environment.

As ever, all our leading coverage of the European private equity market will be available to you on Unquote.com, as well as through our numerous weekly alerts. Furthermore, we will be bringing you proprietary news and insight, and engage with you through a plethora of digital platforms and products.

Among the most exciting initiatives is Private Markets+, a personalised members portal for our network of LPs and GPs, accompanied by a monthly newsletter offering impactful content from across the Acuris universe. We will reach out to you all, over the coming weeks, to make sure you are set up to access these new products, starting with the very first edition of the Unquote Digest in early April.

In the meantime, we hope you will enjoy this final issue of the Unquote magazine. This month's selection of analysis couldn't be further away from the gloomy intelligence we were collecting almost a year to this day - instead, it reflects how the market is finding new cause for optimism, be it through the renewed attractiveness of biotech investments or bullish expectations for DACH exits and Nordic carve-outs. We very much look forward to highlighting similarly positive developments in our new digital formats.

Greg Gille
Editor, Unquote